SXTP

What one share of 60 Degrees Pharmaceuticals holds

Pharmaceutical Preparations

Australia previously solely owned a Singaporean subsidiary company, 60P Singapore Pte. Ltd., which dissolved at our election in the second quarter of 2022.

60 Degrees Pharmaceuticals’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.

Per-share figures
Sales$0.70
Profit−$5.43
Capex (buildings and equipment)$0.08
Free cash flow−$5.61
Cash and investments$0.38
Debt$0.06
Book value$0.98

Per share by fiscal year

YearSalesProfitCapexFree cashDividendsBook value
2023$15.30−$236.73$3.48−$277.50—$201.15
2024$5.35−$74.17$0.91−$50.60—$28.47
2025$1.50−$11.73$0.21−$10.43—$2.98

Common questions about 60 Degrees Pharmaceuticals

How much does one share of 60 Degrees Pharmaceuticals earn?

Over the last 12 months, 60 Degrees Pharmaceuticals lost $5.43 for each share on $0.70 of sales.

Does 60 Degrees Pharmaceuticals pay a dividend?

60 Degrees Pharmaceuticals didn’t pay a dividend over the last 12 months, according to its SEC filings.

What is 60 Degrees Pharmaceuticals’s book value per share?

60 Degrees Pharmaceuticals’s book value is $0.98 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.

How much cash and debt does each share of 60 Degrees Pharmaceuticals have?

Each share of 60 Degrees Pharmaceuticals has $0.38 of cash and investments and $0.06 of debt, as of June 30, 2026.

What is 60 Degrees Pharmaceuticals’s free cash flow per share?

−$5.61 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.

From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.